"Retrospective Study of the Risk of Pathology in the Mandibular Second Molar Associated With an Impacted Third Molar: Development and Validation of a Semi-Automated Artificial Intelligence-Based Digitisation Platform". (SMART-M3)

November 8, 2026 updated by: Carlos Pérez-Albacete Martínez, Universidad Católica San Antonio de Murcia

Impacted mandibular third molars (wisdom teeth that cannot fully erupt) may damage the adjacent second molar, causing decay on its back surface, loss of the supporting bone or resorption of its root. These problems are often silent and are detected late. This retrospective observational study aims to identify which radiographic features of the impacted third molar are associated with a higher risk of pathology in the second molar.

The study uses panoramic radiographs (OPG) and cone-beam computed tomography (CBCT) scans that were previously obtained for clinical reasons at the UCAM Dental University Clinic (Murcia, Spain) between 2018 and 2026. No new images or procedures are performed on patients. The position, angulation, depth and contact of the third molar with the second molar are measured, and their relationship with second molar pathology is analysed. The study also compares the information provided by OPG and CBCT and develops and validates a semi-automated, artificial intelligence-based platform to help clinicians make these radiographic measurements faster and more consistently.

Study Overview

Detailed Description

Design. Single-centre, observational, cross-sectional, retrospective study approved by the Ethics Committee of the Universidad Católica San Antonio de Murcia (code CE102517). It follows the Declaration of Helsinki. Informed consent was waived because only pre-existing images obtained for clinical purposes are used. Data are pseudonymised in accordance with Regulation (EU) 2016/679 (GDPR) and Spanish Organic Law 3/2018.

Setting and sample. Consecutive sampling of all eligible images acquired at the UCAM Dental University Clinic between February 2018 and June 2026 with an ORTHOPHOS SL 3D unit (Dentsply Sirona). The unit of analysis is the mandibular third molar, so each patient may contribute one to four records (one or two third molars, on OPG, CBCT or both). The expected sample is approximately 2,110 third molars from 1,188 patients on OPG and approximately 690 third molars from 384 patients on CBCT, with a paired OPG-CBCT subsample of 667 teeth.

Variables. Third molar variables are:

  • Winter classification
  • Pell & Gregory depth and ramus relationship
  • Retromolar space
  • Angle between the long axes of the second and third molars
  • Distance from the distal surface of the second molar to the ramus
  • Mesiodistal diameter of the third molar
  • Presence, type and level of contact between the third and second molars Covariates are age, sex and smoking status. Outcome. The primary outcome is a composite of distal pathology of the mandibular second molar, defined as the presence of at least one of the following: distal caries, distal bone loss or external root resorption. Teeth without any of the three are classified as controls. Each component is also recorded separately, with its extent or severity.

Statistical analysis. The analysis comprises:

  • Descriptive statistics, overall and by imaging modality.
  • Bivariate analysis using chi-square or Fisher's exact tests and Mann-Whitney U or Student's t tests, with odds ratios, 95% confidence intervals and correction for multiple comparisons.
  • Multivariable mixed-effects logistic regression with the patient as a random effect, to account for the clustering of teeth within patients.
  • Assessment of the model's discrimination with ROC curves and AUC.
  • Agreement between OPG and CBCT in the paired subsample, using intraclass correlation coefficients, simple and weighted kappa and Bland-Altman analysis, with 95% confidence intervals obtained by patient-clustered bootstrap.
  • Intra-observer reliability on 123 teeth per modality. AI-based platform. A semi-automated digitisation platform based on artificial intelligence (automatic landmark detection) is developed to perform the radiographic measurements. It is validated against expert manual assessment in an independent subsample of 191 third molars (103 OPG and 88 CBCT).

Study Type

Observational

Enrollment (Actual)

1188

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Murcia
      • Murcia, Murcia, Spain, 30008
        • Clínica Universitaria UCAM Dental

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients (18 years or older) who attended the UCAM Dental University Clinic (Murcia, Spain) between February 2018 and June 2026 and had at least one mandibular third molar visible on a panoramic radiograph (OPG) and/or cone-beam computed tomography (CBCT) scan obtained previously for clinical purposes. Patients were identified consecutively through the clinic's records management software (GESDEN).

Description

Inclusion Criteria:

  • Age 18 years or older.
  • Age and sex recorded.
  • At least one mandibular third molar present.
  • OPG and/or CBCT available.

Exclusion Criteria:

  • Absence of the adjacent second mandibular molar.
  • Insufficient diagnositc image quality.
  • Previous surgery altering the anatomy.
  • Cysts or tumours in the third molar region.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: RETROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
OPG cohort

Patients with an impacted mandibular third molar assessed on panoramic radiography.

The radiographic assessment was performed on images that were already available. No additional exposure was required.

CBCT cohort

Subset of patients also assessed on CBCT.

The radiographic assessment was performed on images that were already available. No additional exposure was required.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary
Time Frame: At the time of the radiographic examination (single cross-sectional assessment).

Composite distal pathology of the mandibular second molar (distal caries, distal bone loss and/or external root resorption).

At the time of the radiographic examination (single cross-sectional assessment).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary
Time Frame: At the time of the radiographic examination (single cross-sectional assessment).

Agreement between OPG and CBCT measurements (ICC, weighted kappa, Bland-Altman).

At the time of the radiographic examination (single cross-sectional assessment).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 31, 2025

Primary Completion (Actual)

July 30, 2026

Study Completion (Estimated)

December 15, 2026

Study Registration Dates

First Submitted

November 8, 2026

First Submitted That Met QC Criteria

November 8, 2026

First Posted (Actual)

November 13, 2026

Study Record Updates

Last Update Posted (Actual)

November 13, 2026

Last Update Submitted That Met QC Criteria

November 8, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Pseudonymised clinical images subject to GDPR; data available from the corresponding author upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe